UN mission in Ukraine has no powers to assess situation in Crimea, diplomats noteWorld September 25, 21:11
Gentlefan continues: Manchester United fans to get raincoats ahead of encounter with CSKASport September 25, 20:30
US-led coalition denies charges of US units leading Syrian 'opposition' through IS linesWorld September 25, 18:49
Supplies of S-400 systems to Turkey may begin within two yearsMilitary & Defense September 25, 18:14
Ukraine involved in illegal arms deliveries to South Sudan — Amnesty InternationalWorld September 25, 18:01
Russian general's death in Syria result of US double-dealing in war on terror — diplomatRussian Politics & Diplomacy September 25, 17:42
Russia's top diplomat says conditions in Syria ripe for defeating terroristsRussian Politics & Diplomacy September 25, 17:07
Russian envoy notes US actions in Syria as Washington's true colors on anti-terror policyRussian Politics & Diplomacy September 25, 17:00
Economy minister believes new technologies will drive Russia’s economyBusiness & Economy September 25, 16:50
MOSCOW, February 19. /TASS/. Russia’s Federal Antimonopoly Service (FAS) wants to introduce obligatory licensing of medicines to combat HIV in Russia to make them more affordable for the population, Lesya Davydova, head of the international economic department of the FAS said on Friday.
Currently, the prices for such medicines are quite high in Russia, which makes the medical treatment unaffordable for a large number of people. At the same time most of the anti-virus medicines are produced abroad and don’t have Russian analogues, she said.
Davydova said that in South Africa after the compulsory licensing of certain drugs (in particular those fighting HIV) the cost of treatment reduced tenfold.
"So here we also see a lot of work we could do,"- she said.
In October 2015, representatives of 19 non-profit organizations to combat HIV appealed to Prime Minister Dmitry Medvedev to introduce compulsory licensing of antiretroviral drugs for the treatment of this disease.
In early February, the founder of the Pharmasyntez pharmaceutical company Vikram Puniya addressed to Russian President Vladimir Putin with a proposal to apply the mechanism of forced licensing of hepatitis drugs. Puniya also referred to the experience of the BRICS countries in this field. Putin promised to analyze the legal side of the case, and if such practice exists in other countries, to consider the proposal.